Razadyne ER

See also: Generic Razadyne

Razadyne ER is a brand name of galantamine, approved by the FDA in the following formulation(s):

RAZADYNE ER (galantamine hydrobromide - capsule, extended release; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: April 1, 2005
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[RLD][AB]

Has a generic version of Razadyne ER been approved?

A generic version of Razadyne ER has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Razadyne ER and have been approved by the FDA:

galantamine hydrobromide capsule, extended release; oral

• 
  Manufacturer: BARR
  
  Approval date: September 15, 2008
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: IMPAX LABS
  
  Approval date: May 27, 2009
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: January 24, 2011
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: February 2, 2011
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: December 15, 2008
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Razadyne ER. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Controlled release galantamine composition
  Patent 7,160,559
  Issued: January 9, 2007
  Inventor(s): McGee; John Paul & Gilis; Paul Marie Victor & De Weer; Marc Maurice Germain & de Condé; Valentin Florent Victor & de Bruijn; Herman Johannes Catherina & Van Dycke; Frederic Anne Rodolf
  Assignee(s): Janssen Pharmaceutica N.V.
  The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
  
  Patent expiration dates:
  
  
  • December 20, 2019
    
    ✓ 
    Drug product
  
  

See also...

• Razadyne ER Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Razadyne ER Consumer Information (Cerner Multum)
• Razadyne ER Advanced Consumer Information (Micromedex)
• Galantamine Consumer Information (Wolters Kluwer)
• Galantamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Galantamine Solution Consumer Information (Wolters Kluwer)
• Galantamine Consumer Information (Cerner Multum)
• Galantamine Advanced Consumer Information (Micromedex)
• Galantamine Hydrobromide AHFS DI Monographs (ASHP)